Augma Biomaterials - Innovative Dental Bone Graft Cement
|
Company Profile AUGMA Biomaterials Ltd. is a global leader in innovation and discovery of dental materials. Augma develops bone substitute materials for bone augmentation in maxillofacial surgical procedures. The AUGMA 3D Bond and Bond Apatite materials are based on Diphasic Calcium Sulphate cement which makes it usable in the presence of blood and saliva. The patented chemical formula has been patented and approved by the FDA. Plain and simple, AUGMA... Read moreAUGMA Biomaterials Ltd. is a global leader in innovation and discovery of dental materials. Augma develops bone substitute materials for bone augmentation in maxillofacial surgical procedures.
The AUGMA 3D Bond and Bond Apatite materials are based on Diphasic Calcium Sulphate cement which makes it usable in the presence of blood and saliva. The patented chemical formula has been patented and approved by the FDA. Plain and simple, AUGMA materials are the fastest, easiest, and most efficient bone augmentation materials ever available on the market.
AUGMA 3D Bond and AUGMA Bond Apatite are both FDA cleared and CE approved and are packed and marketed in specially designed syringes of 1cc and .5cc.
| Company News
|
Products
Augma Biomaterials is introducing the fastest, easiest and most efficient bone augmentation material the market has ever seen.
Easy to prepare & use, delivered in a dual-chamber, pre-filled syringe, containing the granulated powder and physiological saline.
Convenient to work with and shape – significantly reduces treatment time and makes the clinician’s work easier.
Business Opportunity
Augma is seeking to connect with distributors in the US and EU markets.
Dental Equipment & Products
